Nevertheless, there are many GEFs (including SOS2) that can replace the function of SOS1; hence, it is unclear whether inhibiting SOS1 alone is sufficient to reduce KRAS signaling in humans to prevent cancer [41]. The gene discussed is KRAS; the disease is cancer.